Recruiting Multiple Sclerosis Studies in New Haven
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
The main objectives of the study are to demonstrate pharmacokinetics (PK) similarity between ABP 692 and Ocrelizumab (US), and ABP 692 and Ocrelizumab (EU), and to demonstrate pharmacodynamics (PD) si...
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
This study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS. All eligible participants will be initiated...
About Multiple Sclerosis Clinical Trials in New Haven
Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.
There are currently 2 multiple sclerosis clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 567 participants. Research is being sponsored by Amgen, National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Sclerosis Clinical Trials in New Haven — FAQ
Are there multiple sclerosis clinical trials in New Haven?
Yes, there are 2 multiple sclerosis clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What multiple sclerosis treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.
Data updated March 2, 2026 from ClinicalTrials.gov